Diabetic nephropathy and apolipoprotein E2 allele
糖尿病肾病与载脂蛋白E2等位基因
基本信息
- 批准号:12671128
- 负责人:
- 金额:$ 1.6万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Previously we demonstrated that the apolipoprotein (apo) E e2 allele is associated with the progression of diabetic nephropathy. The aim of the present study is to further investigate the association between apo E genetic polymorphism, plasma remnant lipoproteins and diabetic nephropathy. One hundred and fifty eight type 2 diabetic patients who had a diabetes duration over 10 years were divided into the 3 apo E groups ; apo E2, E3/3 and E4.Plasma levels of lipids and remnant lipoproteins were measured.The effect of apo E2 triglyceride (TG)-rich lipoproteins including remnant lipoproteins on accumulation of cholesteryl esters by human mesangial cells (HMCs) was estimated by measurement of the stimulation of 14C-oleate incorporation into cholesteryl esters. The frequency of overt nephropathy was significant^ higher in apo E2 diabetic patients (59.1%) than in apo E3/3 (34.3%) or apo E4 patients (8 8%) and the frequency of normoalbuminuria was significantly higher in apo E4 diabetic patients (67 6%) than in apo E3/3 (34.3%) or apo E2 patients (4.5%). Logistical regression analysis showed that odds ratios of apo E2 and apo E4 genotypes for the presence of overt nephropathy were 10.179 (p=00349) and 0.129 (p=0.0028), respectively. Plasma levels of triglyceride and remnant-like lipoprotein particles (RLP)-chol and were significantly higher in apo E2 patients, and significantly lower, n apo E4 patients than in apo E3/3 patients. Apo E2 TG-rich lipoproteins stimulated accumulate of cholesteryl esters by HMCs significantly more than apo E3/3 or apo E4 TG-rich lipoproteins. Apo E2, s a positive genetic factor and apo E4 is a negative genetic factor for diabetic nephropathy. Apo E2 TG-rich lipoproteins were uptaken more avidly by HMCs. Remnant lipoproteins may have an important role in the progression of diabetic nephropathy.
以前,我们证明了载脂蛋白(APO)E E2等位基因与糖尿病肾病的进展有关。本研究的目的是进一步研究Apo e遗传多态性,血浆残留脂蛋白和糖尿病性肾病之间的关联。一百五十八名2型糖尿病患者在10年内糖尿病持续时间分为3个APO E组。测量了Apo E2,E3/3和E4。脂质和残留脂蛋白的铂水平是测量的。ApoE2 E2甘油三酸酯(TG) - 富含脂蛋白(包括残留脂蛋白)对通过人膜细胞(HMCS)估算胆汁脂蛋白积累的富含脂蛋白的影响(HMCS)的影响刺激14c-Oleate掺入胆固醇酯中。 APO E2糖尿病患者(59.1%)明显的明显肾病的频率比APO E3/3(34.3%)或APO E4患者(8%)(8%)高,而Normoalbuminuria的频率明显高于APO E4糖尿病患者(67 6%)比APO E3/3(34.3%)或APO E2患者(4.5%)。后勤回归分析表明,对于明显的肾病的存在的APO E2和APO E4基因型的优势比分别为10.179(P = 00349)和0.129(P = 0.0028)。血浆甘油三酸酯和残留样脂蛋白颗粒(RLP) - 胆碱的水平明显更高,而NAPO E4患者明显低于APO E3/3患者。富含APO E2 TG的脂蛋白刺激HMC刺激胆固醇酯的积累,其高于APO E3/3或APO E4 TG富含脂蛋白。 APO E2,S阳性遗传因子和Apo E4是糖尿病性肾病的负遗传因子。 HMCS更加狂热地吸收了富含APO E2 TG TG的脂蛋白。残留的脂蛋白可能在糖尿病肾病的进展中起重要作用。
项目成果
期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Iwashima Y,Eto M,Hata A,Kaku K,Horiuchi S,Ushibuki F,Sano H,: "Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages."Biochem.Biophys.Res.Comm.. 277. 368-380 (2000)
Iwashima Y、Eto M、Hata A、Kaku K、Horiuchi S、Ushibuki F、Sano H,:“培养的人单核细胞来源的巨噬细胞中高级糖基化终末产物诱导清道夫受体的基因表达。”Biochem.Biophys.Res.Comm
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Eto M, Saito M, Kaku K, et al.: "Apolipoprotein E genetic polymorphism, remanat lipoproteins and nephropathy in type 2 diabetic patients."American J Kidney Diseases. (2002)
Eto M、Saito M、Kaku K 等人:“载脂蛋白 E 遗传多态性、残余脂蛋白和 2 型糖尿病患者的肾病。”美国肾脏病杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
SaitoM, EtoM, KakuK.: "Remant-like lipoprotein particles (RLP) in type 2 diabetic patients with apolipoprotein E3/3 genotype and with apolipoprotein E2 genotypes"Metabolism. (2002)
SaitoM、EtoM、KakuK.:“具有载脂蛋白 E3/3 基因型和载脂蛋白 E2 基因型的 2 型糖尿病患者中的残余样脂蛋白颗粒 (RLP)”代谢。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
IwashimaY, Eto M, HataA, Kaku K, Horiuchi S, Ushibuki F, SanoH: "Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages."Biochem. Biophys. Res. Comm.. 277. 368-380 (2000)
IwashimaY、Eto M、HataA、Kaku K、Horiuchi S、Ushibuki F、SanoH:“在培养的人单核细胞来源的巨噬细胞中,高级糖基化终末产物诱导清道夫受体的基因表达。”Biochem。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Eto M, Saito M, Kaku K, et al.: "Type III hyperlipoproteinemia with apolipoprotein E2/2 genotype in Japan."Clinical Genetics. (2002)
Eto M、Saito M、Kaku K 等人:“日本载脂蛋白 E2/2 基因型的 III 型高脂蛋白血症。”临床遗传学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ETO Masaaki其他文献
ETO Masaaki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ETO Masaaki', 18)}}的其他基金
Risk factors for diabetic nephropathy (apolipoprotein E2 allele and remnant lipoproteins) and drug intervention
糖尿病肾病的危险因素(载脂蛋白E2等位基因和残余脂蛋白)及药物干预
- 批准号:
19590155 - 财政年份:2007
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study on the mechanism by which apolipoprotein(apo) E2 promotes diabetic nephropathy
载脂蛋白(apo)E2促进糖尿病肾病的机制研究
- 批准号:
14571112 - 财政年份:2002
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study on the significance of apo E in aherosclerosis
apo E在动脉粥样硬化中的意义研究
- 批准号:
05670407 - 财政年份:1993
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
转铁蛋白糖基化调控Hippo/YAP通路促进肾小管上皮细胞铁死亡对糖尿病肾病的影响和机制研究
- 批准号:82360161
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
纳米盘调控脂质代谢稳态用于改善糖尿病肾病炎性损伤研究
- 批准号:82304422
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于糖酵解代谢重编程机制的糖尿病肾病MRI预后评估研究
- 批准号:82371942
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于AGEs-RAGE通路改善糖尿病肾病的香椿子柠檬苦素型三萜的快速识别及活性研究
- 批准号:82304700
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
吡咯生物碱DM14靶向结合肾小管上皮细胞GRK2延缓糖尿病肾病进展的作用机制研究
- 批准号:82370696
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Ceramides as Novel Mediators of Tubular Metabolic Dysfunction Driving Kidney Injury
神经酰胺作为肾小管代谢功能障碍驱动肾损伤的新型调节剂
- 批准号:
10677394 - 财政年份:2023
- 资助金额:
$ 1.6万 - 项目类别:
Mitochondrial electron transport dysfunction: Dissecting pathomechanisms
线粒体电子传递功能障碍:剖析病理机制
- 批准号:
10679988 - 财政年份:2023
- 资助金额:
$ 1.6万 - 项目类别:
Targeted Automated Nephrology e-Consultation for Diabetic Kidney Disease
糖尿病肾病有针对性的自动化肾病电子咨询
- 批准号:
10591976 - 财政年份:2023
- 资助金额:
$ 1.6万 - 项目类别:
Complete inhibition of ROCK signaling in diabetic nephropathy
完全抑制糖尿病肾病中的 ROCK 信号传导
- 批准号:
23K07709 - 财政年份:2023
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)